Search research articles
Contact Us
Filters
Showing results (191-200 of 218) with videos related to
Page
of 22
Sort By:
Cancer Biomarkers : Section a of Disease Markers
|
April 26, 2018
Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma
A Fricke, A F V Cimniak, P V Ullrich, et al.
Blood Cancer Journal
|
August 23, 2014
Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice
C Sprissler, D Belenki, H Maurer, et al.
The Journal of Molecular Diagnostics : JMD
|
May 13, 2014
Detection of gene rearrangements in targeted clinical next-generation sequencing
Haley J Abel, Hussam Al-Kateb, Catherine E Cottrell, et al.
Neurogastroenterology and Motility
|
January 10, 2023
A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis
Thomas L Abell, Braden Kuo, Tuba Esfandyari, et al.
The Journal of Molecular Diagnostics : JMD
|
July 10, 2021
A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows: A Report of the Association for Molecular Pathology Training and Education Committee
Jason N Rosenbaum, Anna B Berry, Alanna J Church, et al.
Oncotarget
|
February 10, 2018
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer
Perry Grigsby, Adnan Elhammali, Fiona Ruiz, et al.
Cancer Medicine
|
February 26, 2015
BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
Lauren E Henke, John D Pfeifer, Changquing Ma, et al.
Oncogene
|
October 1, 2013
Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression
F Bengsch, A Buck, S C Günther, et al.
BMJ Open Respiratory Research
|
July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
John Belperio, Tuan Nguyen, David A Lombardi, et al.
Oncogene
|
April 30, 2013
Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms
P Tripathi, Y Wang, M Coussens, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 218) with videos related to
Sort By:
Page
of 22
Cancer Biomarkers : Section a of Disease Markers
|
April 26, 2018
Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma
A Fricke, A F V Cimniak, P V Ullrich, et al.
Blood Cancer Journal
|
August 23, 2014
Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice
C Sprissler, D Belenki, H Maurer, et al.
The Journal of Molecular Diagnostics : JMD
|
May 13, 2014
Detection of gene rearrangements in targeted clinical next-generation sequencing
Haley J Abel, Hussam Al-Kateb, Catherine E Cottrell, et al.
Neurogastroenterology and Motility
|
January 10, 2023
A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis
Thomas L Abell, Braden Kuo, Tuba Esfandyari, et al.
The Journal of Molecular Diagnostics : JMD
|
July 10, 2021
A Curriculum for Genomic Education of Molecular Genetic Pathology Fellows: A Report of the Association for Molecular Pathology Training and Education Committee
Jason N Rosenbaum, Anna B Berry, Alanna J Church, et al.
Oncotarget
|
February 10, 2018
Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer
Perry Grigsby, Adnan Elhammali, Fiona Ruiz, et al.
Cancer Medicine
|
February 26, 2015
BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
Lauren E Henke, John D Pfeifer, Changquing Ma, et al.
Oncogene
|
October 1, 2013
Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression
F Bengsch, A Buck, S C Günther, et al.
BMJ Open Respiratory Research
|
July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
John Belperio, Tuan Nguyen, David A Lombardi, et al.
Oncogene
|
April 30, 2013
Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms
P Tripathi, Y Wang, M Coussens, et al.
Page
of 22